Office of Licensing & Ventures
Home
|
Inventors
Disclosure Forms
Benefits to Licensing
Process
Policies and Procedures
Learning Center
Resources for Entrepreneurs
|
Industry & Venture Partners
Working with OLV
Duke Startups
Duke NewCo Opportunities
|
Technologies
Search Technologies
Impact of Weight on Quality of Life
|
About OLV
Overview
Team
Employment & Internship Opportunities
News
Contact Us
Location
home
>
about olv
>
news
Printable View
News
Read the latest announcements coming from OLV. Click a headline for details.
About OLV
Overview
Team
Employment & Internship Opportunities
News
Contact Us
Location
Leading Protein Engineering Executive Joins
April 15, 2008
Genes May Help Some Quit Smoking
April 2, 2008
Certain DNA is linked to better results, study finds
Trevena, Inc. Announces $24 Million Series A Financing
March 5, 2008
Drug Discovery Company to Focus on G-Protein Coupled Receptors
Celsion to Proceed with Phase II Pivotal Breast Cancer Trial after Receiving Supportive FDA Response
January 15, 2008
Expects to Initiate Trial in Ten US Centers
Centice raises 11.3 million
January 8, 2008
Phase Bioscience raises $6.6 million
October 24, 2007
Banked Blood Loses Ability to Deliver Oxygen to Tissues
October 8, 2007
Genetic Variant Linked to Odor Perception
September 16, 2007
Separating the Brain's 'Bad' from 'Good' Iron
August 23, 2007
Duke chemists have found a way, by using 'pro-chelators' wrapped in chemical 'cages'
Mice Provide Important Clues to Obsessive-Compulsive Disorder
August 22, 2007
Sentillion's Growth Continues With Strong Q2; Signs 9 New Customers; Sells 94,130 Licenses
July 12, 2007
Expression Analysis Enters Agreement with GeneGo to Provide Functional Analysis Services using "1-2-3 Workflow"
July 10, 2007
Aldagen Adds Three Clinical Sites to its Critical Limb Ischemia Study
July 10, 2007
Aldagen Establishes Manufacturing Facility
July 2, 2007
Advanced Liquid Logic Receives Prestigious Frost & Sullivan Award
June 5, 2007
OREXIGEN™ Therapeutics Initiates CONTRAVE™ Phase III Clinical Trials
May 21, 2007
OREXIGEN™ Therapeutics Completes Initial Public Offering
April 30, 2007
Accunetix Takes Home Student Business Team Honors in Five Ventures
April 13, 2007
Regado Biosciences Raises $23 Million Series C Financing, 2007-03-28
March 27, 2007
Caxton Advantage Life Sciences Fund Led
Bradmer Pharmaceuticals Announced Fourth Quarter and Fiscal Year Operational and Financial Results
March 1, 2007
Page
1
2
of 2
Next 11 »
Copyright © 2008 Duke OLV |
Site Feedback
|
Contact Us
|
Privacy Policy
|
Duke University
|
Duke Medicine